Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Certican
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Certican 0.25mg tablets
0801050AXBDAAAD
|
Certican | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Certican 0.5mg tablets
0801050AXBDACAF
|
Certican | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Certican 0.75mg tablets
0801050AXBDABAE
|
Certican | Everolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.